- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Federal Appeals Court Overturns Dismissal of Class Action Lawsuit Against Matrixx Initiatives
Recent Articles by Benzinga Staff
- Biotech Stock Mailbag: Generex (PFE, MNKD)
- Apple Is Hoping To Have Apps For That (AAPL)
- Potential Reversals 3/19/10
- Coal Prices Ready To Burn Hot In 2010?
- Stifel Nicolaus Still Gives TriQuint A Buy (TQNT)
Company News
- Tiffany Reports Earnings Monday Morning (TIF)
- Carl Icahn Makes Hostile Takeover Bid For Lions Gate Entertainment (LGF)
- Ex-Cadbury Executive To Head Kraft’s Confectionery Unit (KFT)
- Morningstar Acquires Realpoint LLC (MORN)
- Pfizer Eyes German Drug Maker Stada (PFE, TEVA)
FDA
Posted on 10/28/09 at 1:12pm by Benzinga Staff
Federal Appeals Court overturns dismissal of class action lawsuit against Matrixx Initiatives (Nasdaq: MTXX). There is a class action lawsuit for people that were negatively affected by Matrixx's Zicam product.
Bookmark/Search this post with:
Related Articles
Today's Trading Ideas
Featured Articles
Related News from the Stock Market
- Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference
- Matrixx Initiatives, Inc. Reports Fiscal 2010 Third Quarter Sales of $28.5 Million and Net Income of $3.8 Million
- Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2010 Financial Results
- Semi-Annual Changes to the NASDAQ Biotechnology Index
- New 52-Week Lows (PED, BUSE, FRGB, MTXX)
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
Post new comment
Receive Benzinga's Best 2010 Stock Idea!
